Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released its redesigned blood oxygen monitoring feature. This is just the latest update in the lengthy legal saga between Masimo and Apple, which started when the former sued the iPhonemaker in 2021, accusing it of infringing on several of its light-based blood oxygen monitoring patents. After a court sided with Masimo in 2023, Apple was forced to stop selling the Watch Series 9 and the Ultra 2 in the US for a few weeks. <br /> In order to circumvent the import ban for the devices, Apple removed the Blood Oxygen app for the watch models sold in the US. Just a few days ago, however, the company in [...]
Apple is making another attempt to appeal the trade ban that forced it to remove the blood oxygen sensor from its smartwatches, Reuters reports. The company was forced to remove the feature in 2024, f [...]
In a longstanding and complicated legal battle between Apple and Masimo, a recent ruling from a California jury may be the first step towards a certain conclusion. As reported by Reuters, a federal ju [...]
More than a year after an import ban forced the company to remove blood oxygen monitoring from some US Apple Watch models, Apple says it will introduce a redesigned version of the feature later today. [...]
The day has finally arrived: Today at 1PM ET, Apple is all but certain to unveil the iPhone 17 line. This year is shaping up to be a departure from recent September product rollouts, with the strong p [...]
It's now just a few hours away: At 1PM ET on Tuesday, Apple is all but certain to unveil the iPhone 17 line. This year's theme of "Awe dropping," which was featured in Apple's [...]